RxDoctor Payments Data

David Paulson, PA

Physician Assistant · Lillington, NCNPI 1912026519

Payments from drug & device makers

$4,306in general payments, 2019–2025

Across 253 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$556
  • Amgen$457
  • AbbVie$376
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$277
  • Collegium Pharmaceutical, Inc.$265
  • Biohaven Pharmaceuticals, Inc.$238
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$4,301100%
  • Education$50%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,306 in reported general payments places this provider in the 90th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$11,560
Medicare patients
42
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aimovig AutoinjectorErenumab-Aooe14$11,976
LinzessLinaclotide17$10,692
BelbucaBuprenorphine Hcl11$10,114
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen248$9,056
MovantikNaloxegol Oxalate19$8,299
Xtampza ErOxycodone Myristate24$8,262
Repatha SureclickEvolocumab13$8,138
Buprenorphine19$4,018
Oxycodone Hcl163$3,866
Morphine Sulfate ErMorphine Sulfate79$1,226
Albuterol Sulfate HfaAlbuterol Sulfate45$1,086
Gabapentin49$765
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$732
Ondansetron OdtOndansetron22$554
Pregabalin27$511

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$265$18,37635 claims
AbbVieLinzess$376$10,69217 claims
Redhill Biopharma Inc.Movantik$134$8,29919 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine Hcl$43$4,39632 claims
Almatica Pharma LLCSertraline Hcl$126$7311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Lillington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →